A Tumor-homing nanoplatform for the co-delivery of triptolide and siRNA-A4B2 conspicuously overcomes peritoneum metastasis of ovarian cancer
Together, these findings present a novel strategy to overcome the peritoneal metastasis tendency of ovarian cancer and offer a potential therapeutic solution for clinical treatment of ovarian cancer. The combination of traditional Chinese medicine nano drug delivery platforms provides a new perspective for cancer treatment.
Authors
- Chenhuan Ding (ORCID: https://orcid.org/0000-0003-2534-8946)
- Junfeng Guo
- Yingbin Wang (ORCID: https://orcid.org/0000-0001-8575-065X)
- He Li
- Chen Wang (ORCID: https://orcid.org/0000-0003-3912-5321)
- Yi Lai (ORCID: https://orcid.org/0009-0007-2673-4618)
Institutions
- Renji Hospital (CN)
- Quzhou City People's Hospital (CN)
- State Key Laboratory of Oncogene and Related Genes (CN)
Publication Details
- Journal
- Cellular Oncology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s13402-025-01104-2
- Primary Topic
- Natural Compounds in Disease Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00